University of Vienna
High-field MRI provides a wealth of information when contrast is used
Published in Mental Health Business Week, April 24th, 2004
"The basic diagnostic efficacy of magnetic resonance (MR) contrast medium in the evaluation of primary brain tumors and its clinical usefulness in the detection of brain metastases with single and cumulative triple-close was compared using a high-field 3T MR unit and a 1.5T MR unit. Additionally, the effect of contrast agent on high-resolution MR venography based on the BOLD effect was evaluated at both field strengths," scientists writing in the journal Radiologe report.
"Tumor-brain contrast after gadodiamide administration, as assessed by means of statistical evaluation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Amarin Corporation plc
Neuroscience pharmaceutical firm reports 4Q loss of $0.25 per share - Decision Resources
Report announces leader in neurology drug market - Jazz Pharmaceuticals, Inc.
Maker of neurological/psychiatric drugs announces $250M financing - Mental Health
Mental health faces impending crisis in South Carolina - NEUROMetrix, Inc.
Neurological-device company raises $10 million in additional venture financing - American Psychological Association Practice Direct
Americans say money is number one cause of stress - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
